# FDA Inspection 1293932 - Betta Pharmaceuticals Co., Ltd.-Site C - November 13, 2025

Source: https://www.keypedia.com/records/fda_inspections/betta-pharmaceuticals-co-ltd-site-c/3fbfab0a-c6dd-432b-8183-b10aa0cf2279
Source feed: FDA_Inspections

> FDA Inspection 1293932 for Betta Pharmaceuticals Co., Ltd.-Site C on November 13, 2025. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293932
- Company Name: Betta Pharmaceuticals Co., Ltd.-Site C
- Inspection Date: 2025-11-13
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1293932 - 2025-11-13](https://www.keypedia.com/records/fda_inspections/betta-pharmaceuticals-co-ltd-site-c/f2a44120-9976-4267-bf92-5f350f10414b)

Company: https://www.keypedia.com/companies/betta-pharmaceuticals-co-ltd-site-c/cad2d6c7-7a12-416d-a805-1e9cc5e6f42c

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c